Publicacions en què col·labora amb Luis Gandía Juan (6)

2016

  1. N-Benzylpiperidine Derivatives as α7 Nicotinic Receptor Antagonists

    ACS Chemical Neuroscience, Vol. 7, Núm. 8, pp. 1157-1165

2011

  1. Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3- carbonitriles

    Bioorganic and Medicinal Chemistry, Vol. 19, Núm. 1, pp. 122-133

  2. Synthesis, biological assessment and molecular modeling of new dihydroquinoline-3-carboxamides and dihydroquinoline-3-carbohydrazide derivatives as cholinesterase inhibitors, and Ca channel antagonists

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 1, pp. 1-10

2010

  1. Computational analysis of the binding ability of heterocyclic and conformationally constrained epibatidine analogs in the neuronal nicotinic acetylcholine receptor

    Molecular Diversity, Vol. 14, Núm. 2, pp. 201-211

  2. Erratum: Computational analysis of the binding ability of heterocyclic and conformationally constrained epibatidine analogs in the neuronal nicotinic acetylcholine receptor (Mol Divers DOI: 10.1007/s11030-009-9161-9)

    Molecular Diversity

  3. Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles

    Bioorganic and Medicinal Chemistry, Vol. 18, Núm. 16, pp. 5861-5872